School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Pancreas Translational and Clinical Research Center, Pancreatic Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Ann Surg Oncol. 2023 Jun;30(6):3466-3477. doi: 10.1245/s10434-023-13117-y. Epub 2023 Feb 11.
The prognosis of nodal recurrence after surgery for non-functioning pancreatic neuroendocrine tumors (NF-PanNETs) and its predictors have been poorly investigated. This study aimed to compare clinicopathologic features and survival between patients with nodal relapse and those with distant relapse and to identify predictors of nodal relapse after surgery for NF-PanNETs.
All patients (n = 321) submitted to surgery for NF-PanNETs were included. Nodal recurrence was defined as the presence of one or more enlarged LNs at high-quality radiologic examinations and always confirmed by Ga-DOTA-PET or biopsy.
Altogether, 21 patients (6 %) experienced nodal (± distant) relapse, and 35 patients (11 %) had distant recurrence alone. Isolated nodal recurrence occurred for 23 % of patients with recurrence. Overall, 11 patients died of disease, one of whom (pT3N1G3) had an isolated nodal relapse. The rate of LN metastases (81 % vs 54 %; p = 0.044) and median number of positive LNs (PLN) (3 vs 0; p = 0.019) both were significantly higher for the patients with nodal (± distant) relapse than for those with distant relapse alone. Microvascular invasion (p = 0.046), T stage (p = 0.004), N stage (N1 [p = 0.049]; N2 [p = 0.001]), M stage (p < 0.001), and necrosis (p = 0.011) independently predicted nodal relapse. After distal pancreatectomy (n = 182), 13 patients experienced nodal recurrence, 9 of whom had left paraortic LNs involvement.
Lymph nodes are not rare sites of recurrence after surgery for NF-PanNETs. Lymph node involvement is a powerful determinant of nodal relapse. Nodal relapse frequently involves LNs that are not removed during standard lymphadenectomy.
对于无功能性胰腺神经内分泌肿瘤(NF-PanNETs)患者术后淋巴结复发的预后及其预测因素的研究甚少。本研究旨在比较淋巴结复发和远处复发患者的临床病理特征和生存情况,并确定 NF-PanNETs 术后淋巴结复发的预测因素。
纳入所有接受 NF-PanNETs 手术的患者(n=321)。淋巴结复发定义为高质量影像学检查发现一个或多个淋巴结肿大,并经 Ga-DOTA-PET 或活检证实。
共有 21 例(6%)患者出现淋巴结(±远处)复发,35 例(11%)患者仅出现远处复发。复发患者中有 23%出现孤立性淋巴结复发。共有 11 例患者死于疾病,其中 1 例(pT3N1G3)仅出现孤立性淋巴结复发。淋巴结转移率(81% vs 54%;p=0.044)和阳性淋巴结数量(PLN)中位数(3 枚 vs 0 枚;p=0.019)均显著高于淋巴结(±远处)复发患者和仅远处复发患者。微血管侵犯(p=0.046)、T 分期(p=0.004)、N 分期(N1 [p=0.049];N2 [p=0.001])、M 分期(p<0.001)和坏死(p=0.011)均独立预测淋巴结复发。行远端胰腺切除术(n=182)后,13 例患者出现淋巴结复发,其中 9 例左侧腹主动脉旁淋巴结受累。
淋巴结是 NF-PanNETs 术后复发的常见部位。淋巴结受累是淋巴结复发的有力决定因素。淋巴结复发常累及标准淋巴结清扫术未切除的淋巴结。